The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review

Familial hypercholesterolemia (FH) is a genetic disorder that leads to elevated plasma LDL-cholesterol levels and premature coronary heart disease (CHD). An understanding of the mutations responsible for FH and the effectiveness of statins in lowering the risk of CHD in FH patients has increased int...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annali di igiene 2017-09, Vol.29 (5), p.464-480
Hauptverfasser:	Rosso, A, Pitini, E, D'Andrea, E, Massimi, A, De Vito, C, Marzuillo, C, Villari, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Cost-Benefit Analysis Databases, Factual Family Health Genetic Testing - economics Genetic Testing - methods High-Throughput Nucleotide Sequencing - economics High-Throughput Nucleotide Sequencing - methods Humans Hyperlipoproteinemia Type II - diagnosis Hyperlipoproteinemia Type II - genetics Mass Screening - economics Mass Screening - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!